View Author
children haart study patient score infection growth lamivudine effect weight baseline therapy treatment group regimen screening antiretroviral immunodeficiency height hiv-infected children change 96 weeks lifetime health-care costs indinavir hiv-infected virus analysis antiretroviral therapy pretreated patients women t-cell increase health-care lifetime immunodeficiency virus infection rna levels parameter responder side effects level height z score pretreated health pregnancy 48 weeks cost-effectiveness weight z score hiv infection number transmission bmi z score virologic table haart initiation nonresponder inhibitor delivery netherland range difference virologic responders week 48 count amsterdam zidovudine disease life-expectancy value ritonavir initiation prevalence hospital pediatrics erasmus rotterdam pharmacokinetic sensitivity analysis 500 copies /ml center adult medication
4 Most Recent Publications
|
Cost-effectiveness estimates for antenatal HIV testing in the Netherlands
(Article)
Rozenbaum, M.H. Verweel, G. Folkerts, D.K.F. Dronkers, F. Hoek, J.A.R. van den Hartwig, N.G. Groot, R. de Postma, M.J. |
2008-10-01
|
|
Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment
(Article)
Fraaij, P.L.A. Verweel, G. Rossum, A.M.C. van Hartwig, N.G. Burger, D.M. Groot, R. de |
2007-06-01
|
|
Age-dependent pharmacokinetics of lamivudine in HIV-infected children
(Article)
Burger, D.M. Verweel, G. Gibb, D.M. Groot, R. de Rakhmanina, N.Y. Verwey-Van Wissen, C.P.W.G.M. La Porte, C.J.L. Bergshoeff, A.S. Lyall, H. Hartwig, N.G. Green, H. Soldin, S. |
2007-05-10
|
|
Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth
(Article)
Verweel, G. Hartwig, N.G. Scherpbier, H.J. Groot, R. de Wolfs, T.F.W. Rossum, A.M.C. van |
2002-01-01
|
